<DOC>
	<DOC>NCT01741129</DOC>
	<brief_summary>The investigators aimed to compare the efficacy of nasal intermittent mandatory ventilation (IMV) and nasal continuous positive airway pressure (CPAP) in early rescue surfactant treatment in preterm infants.</brief_summary>
	<brief_title>Comparison of Effectiveness of Nasal CPAP and Nasal IMV in Early Rescue Surfactant Treatment in Preterm Infants</brief_title>
	<detailed_description />
	<mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
	<mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
	<mesh_term>Pulmonary Surfactants</mesh_term>
	<criteria>Gestational age 2632 weeks The criteria for failure were met by at least 1 of the following: pH: 7.10 and PaCO2: 70 mm Hg Recurrent apnea with &gt;3 episodes (Prophylactic caffeine were used in all infants) Single episode of apnea that required bagandmask ventilation PaO2: 50 mmHg with a fraction of inspired oxygen of &gt;0.5. Major congenital anomalies Presence of cardiovascular instability Intubation at admission to the NICU Consent not provided or refused</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>2 Hours</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Nasal CPAP</keyword>
	<keyword>Nasal IMV</keyword>
	<keyword>Surfactant</keyword>
	<keyword>Preterm infants</keyword>
</DOC>